Pepper Bio

1:15 PM - 1:30 PM (PDT), Monday, June 13, 2022
Pepper Bio has developed the world’s first transomic drug discovery platform. We integrate phosphoproteomics, proteomics, transcriptomics, and genomics. This whole-stack solution to common drug discovery challenges reveals actionable insights that others miss. This talk will showcase our technology, it’s capabilities, and share case studies in oncology and inflammatory bowel disease.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Head of Business Development
Pepper Bio